These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 21377481

  • 1. The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study.
    Brown VL, Jane White KA.
    Math Biosci; 2011 Jun; 231(2):126-34. PubMed ID: 21377481
    [Abstract] [Full Text] [Related]

  • 2. [Efficiency of human papillomavirus vaccination--estimates based on Dutch cost effectiveness analyses].
    Westra TA, Daemen T, Postma MJ, Wilschut JC.
    Ned Tijdschr Geneeskd; 2009 Jun; 153():A356. PubMed ID: 19930733
    [Abstract] [Full Text] [Related]

  • 3. The economic impact of HPV vaccines: not just cervical cancer.
    Myers ER.
    Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522
    [No Abstract] [Full Text] [Related]

  • 4. Cost-utility analysis of vaccination against HPV in Israel.
    Ginsberg GM, Fisher M, Ben-Shahar I, Bornstein J.
    Vaccine; 2007 Sep 17; 25(37-38):6677-91. PubMed ID: 17706844
    [Abstract] [Full Text] [Related]

  • 5. A brief history of economic evaluation for human papillomavirus vaccination policy.
    Beutels P, Jit M.
    Sex Health; 2010 Sep 17; 7(3):352-8. PubMed ID: 20719227
    [Abstract] [Full Text] [Related]

  • 6. Cost–effectiveness of catch-up programs in human papillomavirus vaccination.
    de Peuter MA, Littlewood KJ, Annemans L, Largeron N, Quilici S.
    Expert Rev Vaccines; 2010 Oct 17; 9(10):1187-201. PubMed ID: 20923269
    [Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness of human papilloma virus vaccination in Iceland.
    Oddsson K, Johannsson J, Asgeirsdottir TL, Gudnason T.
    Acta Obstet Gynecol Scand; 2009 Oct 17; 88(12):1411-6. PubMed ID: 19900074
    [Abstract] [Full Text] [Related]

  • 8. The cost-effectiveness of male HPV vaccination in the United States.
    Chesson HW, Ekwueme DU, Saraiya M, Dunne EF, Markowitz LE.
    Vaccine; 2011 Oct 26; 29(46):8443-50. PubMed ID: 21816193
    [Abstract] [Full Text] [Related]

  • 9. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
    Ault K, Reisinger K.
    Int J Infect Dis; 2007 Nov 26; 11 Suppl 2():S26-8. PubMed ID: 18162242
    [Abstract] [Full Text] [Related]

  • 10. The HPV vaccination strategy: could male vaccination have a significant impact?
    Brown V, White KA.
    Comput Math Methods Med; 2010 Sep 26; 11(3):223-37. PubMed ID: 20582762
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.
    de Kok IM, van Ballegooijen M, Habbema JD.
    J Natl Cancer Inst; 2009 Aug 05; 101(15):1083-92. PubMed ID: 19571256
    [Abstract] [Full Text] [Related]

  • 12. [Developments in HPV vaccination].
    de Melker H, Kenter G, van Rossum T, Conyn-van Spaendonck M.
    Ned Tijdschr Geneeskd; 2012 Aug 05; 156(47):A5410. PubMed ID: 23171565
    [Abstract] [Full Text] [Related]

  • 13. Health and economic impact associated with a quadrivalent HPV vaccine in Italy.
    Mennini FS, Giorgi Rossi P, Palazzo F, Largeron N.
    Gynecol Oncol; 2009 Feb 05; 112(2):370-6. PubMed ID: 19041125
    [Abstract] [Full Text] [Related]

  • 14. Global human papillomavirus vaccination: can it be cost-effective?
    Crosbie EJ.
    BJOG; 2012 Jan 05; 119(2):125-8. PubMed ID: 22168760
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Insufficient basis for the inclusion of Human papillomavirus vaccination in the National Immunisation Programme in The Netherlands].
    de Kok IM, Habbema JD, Mourits MJ, Coebergh JW, van Leeuwen FE.
    Ned Tijdschr Geneeskd; 2008 Sep 13; 152(37):2001-4. PubMed ID: 18825885
    [Abstract] [Full Text] [Related]

  • 18. Anti-HPV vaccination: a review of recent economic data for Italy.
    Mennini FS, Costa S, Favato G, Picardo M.
    Vaccine; 2009 May 29; 27 Suppl 1():A54-61. PubMed ID: 19480963
    [Abstract] [Full Text] [Related]

  • 19. Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The Netherlands.
    Boot HJ, Wallenburg I, de Melker HE, Mangen MJ, Gerritsen AA, van der Maas NA, Berkhof J, Meijer CJ, Kimman TG.
    Vaccine; 2007 Aug 14; 25(33):6245-56. PubMed ID: 17630049
    [Abstract] [Full Text] [Related]

  • 20. Challenges of implementing human papillomavirus (HPV) vaccination policy.
    Raffle AE.
    BMJ; 2007 Aug 25; 335(7616):375-7. PubMed ID: 17717366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.